Resultados de la búsqueda 361-370 of 15496 for disordered eating

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...

  3. Neurología - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

  5. Mayo Clinic Physician Update - May 2025

    Page 1.

  6. Nutrición y comida saludable Natural family planning - Mayo Clinic

    In: The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Dietary supplements: What you need to know. Office of Dietary Supplements. https://ods.od.

  7. Nutrición y comida saludable Healthy diets - Mayo Clinic

    Add 5 habits. In: The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Dietary supplements: What you need to know. Office of Dietary Supplements. https://ods.

  8. Nutrición y comida saludable Multimedia - Mayo Clinic

    Add 5 habits. In: The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Dietary supplements: What you need to know. Office of Dietary Supplements. https://ods.

  9. Nutrición y comida saludable Nutrition basics - Mayo Clinic

    Mayo Clinic. June 21, 2023. Hensrud DD, ed. Add 5 habits. In: The Mayo Clinic Diet. 3rd ed. Mayo Clinic Press; 2023. Dietary supplements: What you need to know.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...